Tian'an Technology (TANAF) Equity Ratio (2022 - 2025)

Tian'an Technology (TANAF) posted Equity Ratio of 0.12 for Q4 2025, down 332.96% on a QoQ basis from 0.05 in Q2 2025, and down 729.53% year-over-year from 0.02 in Q4 2024.

Tian'an Technology (TANAF) has 4 years of Equity Ratio data on file, last reported at 0.12 in Q4 2025.

  • In Q4 2025, Equity Ratio fell 729.53% year-over-year to 0.12; the TTM figure through Dec 2025 stood at 0.12 (down 729.53% YoY), while the FY2025 annual figure was 0.12, down 729.53% from the prior year.
  • Equity Ratio slipped to 0.12 in Q4 2025, from 0.05 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.05 in Q2 2025 and bottomed at 4.12 in Q4 2022.
  • A 4-year average of 1.77 and a median of 1.3 in 2023 frame the typical range for Equity Ratio.
  • The widest YoY moves for Equity Ratio: up 101.37% in 2025, down 729.53% in 2025.
  • Year by year, Equity Ratio stood at 4.12 in 2022, then advanced by 25.44% to 3.07 in 2023, then surged by 100.64% to 0.02 in 2024, then plunged by 729.53% to 0.12 in 2025.
  • The last three Equity Ratio figures came in at 0.12 (Q4 2025), 0.05 (Q2 2025), and 0.02 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 Tian'an Technology - - - -0.12

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -0.12
Jun 30, 2025 0.05
Dec 31, 2024 0.02
Jun 30, 2024 -3.85
Dec 31, 2023 -3.07
Jun 30, 2023 -1.30
Dec 31, 2022 -4.12